VOLUNTARY DISSOLUTION - LIQUIDATION

THERATOPIX PHARMA

Company — Voluntary dissolution - liquidation.

Financial year 2024 · Closed on 31/12/2024

Net result-205,6 k €-16,0 %over 1 year
Revenue74,8 k €-11,6 %over 1 year
Equity645,5 k €-21,7 %over 1 year
Workforce2,8 ETP-9,7 %over 1 year

Identity

Source · BCE/KBO

THERATOPIX PHARMA is a Public limited company incorporated in 2019. Its registered office is in Liège. It employs on average 2,8 ETP workers (FTE).

Legal situation
Voluntary dissolution - liquidation
BCE/KBO no. / VAT
BE 0738.446.251
Incorporation
26/11/2019
Legal form
Public limited company
Registered office
Rue Louvrex 55-57
4000 Liège · WallonieSee on map
Contributed capital
805 000,00 €
Latest accounts
31/12/2024
Average workforce
2,8 ETP
Joint committees (1)
  • 207
Signals
Solid equityGood liquidityHealthy social debts

Financials

Source · NBB, 5 filings

Trend over 5 financial years

20242023202220212020
Income statement
Revenue74,8 k €84,6 k €39,7 k €––
EBITDA-172,1 k €-145,5 k €-29 k €-32,7 k €-7 k €
Operating result-257 k €-230,8 k €-71 k €-36,3 k €-7,5 k €
Net result-205,6 k €-177,2 k €-50,5 k €-39,9 k €-6,2 k €
Balance sheet
Equity645,5 k €824,6 k €333,9 k €248,5 k €121,8 k €
Total assets950,7 k €1,2 M €705,5 k €650,4 k €257 k €
Cash136,3 k €521,9 k €99,6 k €203,4 k €159,1 k €
Debts304,5 k €405,8 k €370,4 k €401,9 k €135,1 k €
Other
Workforce2,8 ETP3,1 ETP1,8 ETP1,0 ETP1,0 ETP

Board of directors

Source · NBB, accounts to 31/12/2024

5 active · 6 ended

Active mandates

ARNAUD ALLAER GESTION

Mandate · 0506.699.393

Represented by Arnaud ALLAER

Active
Benoît FELLIN

Mandate

Active
NOSHAQ PARTNERS

Mandate · 0808.219.836

Represented by Hélène SABATEL

Active
PHARMBIOSOL

Mandate · 0599.848.790

Represented by Sabine OLIVIER

Active
Vincent BOURS

Mandate

Active

Ended mandates

ARNAUD ALLAER GESTION

Director · since 01 février 2023 · until 01 février 2029 · 0506.699.393

Represented by ARNAUD ALLAER

Ended
BENOIT FELLIN

Director · since 01 février 2023 · until 01 février 2029

Ended
NOSHAQ PARTNERS

Director · since 01 février 2023 · until 01 février 2029 · 0808.219.836

Represented by HELENE SABATEL

Ended
VINCENT BOURS

Director · since 01 février 2023 · until 01 février 2029

Ended

Other companies at this address

Rue Louvrex 55-57 4000 Liège
CompanyCBE no.
0455.591.479
BCH HILL● Liquidation
0700.301.594
0688.854.507
ERGOCONSULT● Liquidation
0651.772.001
EXIMPA● Liquidation
0414.865.832
FHL AVOCAT● Active
0789.713.919
GROUPE MOSAL● Active
0715.620.369
HEDERA 22● Liquidation
0630.923.236
IMMOSAL● Active
0707.919.559
Isosystems● Liquidation
0873.988.014
LASERFLASH● Liquidation
0447.621.346
1011.066.830
LM GESTION● Active
0430.928.834
0556.751.987
MOSAL● Active
0827.814.133
PDC line Pharma● Liquidation
0657.842.221
QUALIBLOOD● Liquidation
0684.698.353
SPARX INDUSTRIES● Liquidation
0476.423.022
0686.711.005
VM Avocat● Active
0785.439.187

Full financial information

Source · NBB
20242023202220212020
Type of accountAbridged modelAbridged modelAbridged modelAbridged modelAbridged model
Start of the financial year01/01/202401/01/202301/01/202201/01/202126/11/2019
Closing of the financial year31/12/202431/12/202331/12/202231/12/202131/12/2020
Length of the financial year12 months12 months12 months12 months14 months
Filing date20/06/202514/06/202409/06/202330/05/202228/05/2021
General meeting20/05/202504/06/202416/05/202303/05/202204/05/2021
Currency of the financial yearEUREUREUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for free

Annual accounts filings

Source · NBB, 5 filings
ModelClosingGeneral meetingFiledLanguageDocument
Abridged model31/12/202420/05/202520/06/2025FrenchPDF
Abridged model31/12/202304/06/202414/06/2024FrenchPDF
Abridged model31/12/202216/05/202309/06/2023FrenchPDF
Abridged model31/12/202103/05/202230/05/2022FrenchPDF
Abridged model31/12/202004/05/202128/05/2021FrenchPDF

Indicative valuation

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2024

5 active · 6 ended

Active mandates

ARNAUD ALLAER GESTION

Mandate · 0506.699.393

Represented by Arnaud ALLAER

Active
Benoît FELLIN

Mandate

Active
NOSHAQ PARTNERS

Mandate · 0808.219.836

Represented by Hélène SABATEL

Active
PHARMBIOSOL

Mandate · 0599.848.790

Represented by Sabine OLIVIER

Active
Vincent BOURS

Mandate

Active

Ended mandates

ARNAUD ALLAER GESTION

Director · since 01 février 2023 · until 01 février 2029 · 0506.699.393

Represented by ARNAUD ALLAER

Ended
BENOIT FELLIN

Director · since 01 février 2023 · until 01 février 2029

Ended
NOSHAQ PARTNERS

Director · since 01 février 2023 · until 01 février 2029 · 0808.219.836

Represented by HELENE SABATEL

Ended
VINCENT BOURS

Director · since 01 février 2023 · until 01 février 2029

Ended

Ownership and network

Looking for more information about this company?

Try for free

Belgian Official Gazette publications

Source · Belgian Official Gazette
  • Registered office04/12/2025
    SIEGE SOCIAL
    PDF
  • Mandates26/08/2025
    RUBRIQUE FIN (CESSATION, ANNULATION CESSATION, NULLITE, CONC, REORGANISATION JUDICIAIRE, ETC...) - SIEGE SOCIAL - DEMISSIONS, NOMINATIONS
    PDF
  • Mandates07/02/2023
    STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, …) - CAPITAL, ACTIONS - DEMISSIONS, NOMINATIONS - ASSEMBLEE GENERALE
    PDF
  • Capital / shares31/05/2021
    STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, …) - CAPITAL, ACTIONS
    PDF
  • Other28/11/2019
    RUBRIQUE CONSTITUTION (NOUVELLE PERSONNE MORALE, OUVERTURE SUCCURSALE, ETC...)
    PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

  1. 2024
    Annual accounts 2024-205,6 k €↓
  2. 2023
    Annual accounts 2023-177,2 k €↓
  3. 2022
    Annual accounts 2022-50,5 k €↓
  4. 2021
    Annual accounts 2021-39,9 k €↓
  5. 2020
    Annual accounts 2020-6,2 k €
  6. 26/11/2019
    IncorporationPublic limited company